Thyroid

Loading...

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

0 comments

Post a comment

    Post a comment
    Embed Video
    Edit your comment Cancel

    Favorites, Groups & Events

    Thyroid - Presentation Transcript

    1. THYROID DISORDERS
      • The thyroid gland
        • secretes thyroxine (T4) and smaller amts of tri-iodothyronine (T3)
          • T3 is three to eight more times potent than T4
          • both modulate energy use, heat production and facilitate growth
        • thyroid hormones exert metabolic effects in several body tissues increasing O2 consumption and heat production which increases metabolic rate
      • Thyroid hormones affect several organ systems which are lacking in hypothyroidism and exaggerate in hyperthyroidism
      • Thyroid evaluation
        • can be evaluated for functional status
          • euthyroid,
          • hypothyroid or
          • Hyperthyroid
        • etiology of dysfunction, or structural abnormalities causing dysfunction
      • Tests of Serum Thyroid Hormone levels
        • Total T4 and T3
          • measures total amt of hormone bound to thyroid binding proteins (TBG) and in the free state by radio-immunoassay
          • Total T4 and Total T3 are elevated in hyperthyroidism and low in hypothyroidism
            • increase in TBG from pregnancy or estrogen tx increases Total T4 and T3 in absence of hyperthyroidism
            • cirrhosis and nephrotic syndrome can lower TBG and thus lower Total T4 and T3
      • Apathetic hyperthyroidism
        • pt’s present w/flat affect, emotional lability, weight loss, muscle weakness, atrial fibrillation resistant to tx or congestive ht failure
      • Separation of nail beds (onycholysis) often occurs in Graves disease
      • Lab findings
        • elevated free T4 and a suppressed TSH confirm Dx for thyrotoxicosis
        • increased uptake of 123I differentiates Graves disease from early sub-acute or Hashimoto’s thyroiditis
          • 123I is low in sub-acute or Hashimoto’s thyroiditis
        • MRI or ulta-sound can show orbital muscle enlargement w/o signs of opthalmopathy
      • Onset may be insidious
      • Atrial fib is rare in young patient but occur in over 50% of males patient over 60 y/o
      • Results from IgG antibodies against the TSH – receptor
      • These antibodies are termed thyroid – stimulating antibodies (TSAb)
      • May be responsible for thyroid enlargement in this disease
      • The cardinal signs of Graves’ disease are:
        • Diffuse goiter
        • Vascular bruit can be heard over these goiters
        • Pretibial myxoedema
        • Tachycardia with a bounding pulse
        • Exophthalmos
        • Lid lag (usually on downward eye movement)
        • Lid retraction
        • Peri-orbital puffiness
        • Increased lacrimation
        • Conjunctival edema and ulceration
      • In the elderly a ‘masked’ hyperthyroidism may be found. If presentation of a 60 y/o with atrial fib, heart failure and weight loss
      • THINK HYPERTHYROIDISM!!!
      • Diagnosis is made clinically with confirmation by labs:
        • T3 and T4 and undetectable TSH levels
        • if a single nodule is suspected a thyroid scan may provide useful information
      • Graves disease tx:
        • Anti-thyroid drugs: thiocarbamide drugs, propylthiouracil, methimazole, and carbimazole block thyroid hormone synthesis
          • propythiouracil partially inhibits peripheral conversion of T4 to T3
          • tx must be given until ds undergoes spontaneous remission (12 to 18 months)
            • only 20-30% remain in remission
            • pts who relapse must undergo surgery or radioactive iodine tx
          • Pts must be instructed to d/c med if sore throat or fever develops -> agranulocytosis
          • beta blockers can be given at onset to alleviate cardiac abnormalities
        • Radioactive iodine 131I
          • in terms of cost, ease, efficacy and short-term side-effects, radioactive iodine has benefits that exceed anti-thyroid drugs or surgery
            • pts w/severe thyrotoxicosis, or very large thyroids should tx’ed first w/anti-thyroid drugs to become euthyroid
          • Pt’s become euthyroid w/radioactive iodine in 3wks to 6 months
          • 10-20% become hypothyroid in first yr
          • 50-80% who receive radioactive tx eventually become hypothyroid
        • Surgery: subtotal thyroidectomy is tx of choice in
        • pt’s as a treatment for thyroid cancer
      • when an enlarged thyroid (goiter) or multiple nodules cause cosmetic, breathing or swallowing problems
      • in a pregnant woman, when her hyperthyroidism is not controllable by antithyroid drugs, and requires immediate treatment
      • when other forms of treatment for hyperthyroidism -- i.e,. antithyroid drugs or radioactive iodine have not been effective. (This is applicable in the U.S. Outside the U.S., surgery is sometimes performed as a hyperthyroidism treatment before or instead of radioactive iodine.)
      • in children, if the practitioner or parent wishes to avoid radioactive iodine
      • when the patient refuses antithyroid medications or radioactive iodine
      • when a patient wants to try to get pregnant quickly after treatment
      • Toxic adenoma
        • solitary toxic nodules occur more frequently in older pt’s
        • usually benign
        • S&S are those of thyrotoxicosis
        • TSH is suppressed w/ high levels of T3 w/a moderate elevation of T4
        • thyroid scan shows a “hot” nodule
        • usually managed w/131I, may need unilateral thyroidectomy if nodule is large
      • Toxic Multi-nodular Goiter
        • occurs in older pts w/long standing multi-nodular goiter
          • S&S usually are tachycardia, heart failure and arrthymias
          • PE reveals a multi-nodular goiter
          • TSH is suppressed, markedly elevated T3 and a moderately elevated T4
          • tx of choice is subtotal thyroidectomy
            • heart disease may be contraindication to surgery
            • toxic nodules tx’ed w/131I
      • Thyroiditis
        • can be classified as acute, sub-acute, or chronic
          • may eventually result in hypothyroidism
          • easily differentiated from other causes of hyperthyroidism by a suppressed 123I uptake
        • Acute suppurative thyroiditis is a rare complication of septicemia
          • S&S: high fever, redness over gland, tenderness
            • may be confused w/sub-acute thyroiditis
            • if blood cultures are neg, needle aspiration can identify organism; tx w/antibiotics or Incision &Drainage (I&D)
      • Sub-acute thyroiditis (de Quervain’s thyroiditis or granulomatous thyroiditis)
        • an acute inflammatory disorder probably due to viral infection
          • resolves in a few months in 90% of pts
          • S&S: hyperthyroidism, fever, anterior neck pain; classical feature is an exquisitely tender gland
          • labs vary w/course of ds: initially T4 is elevated, TSH is suppressed, 123I uptake is very low
          • may fluctuate from euthyroid to hypothyroid and back
        • Increase in 123I on scan reflects recovery of gland
        • tx is usually non-steroidal anti-inflammatory drugs (NSAID’s), short course of prednisone may be needed if fever and pain are severe; levothyroxine may be needed for clinical symptoms of hypothyroidism
      • Chronic Thyroiditis (Hashimoto’s thyroiditis, lymphocytic thyroiditis)
        • results from destruction of normal thyroidal architecture by lymphocytic infiltration resulting in hypothyroidism and goiter
        • Hashimoto’s thyroiditis is more common in women and most common cause of hypothyroidism and goiter in the US
        • Occasionally pts may have transient hyperthyroidism w/ low 123I uptake
        • gland non-tender to palpation
        • serum T4 and T3 are nl or low, when low TSH is elevated
        • FNA reveals lymphocytes and Hurthle cells (enlarged basophilic follicular cells)
        • hypothyroidism and goiter are indications for levothyroxine tx
      • Thyrotoxicosis Factitia
        • presents w/ clinical features of thyrotoxicosis from ingestion of large amts of thyroxine
          • often occurs in an attempt to lose weight
          • TSH is suppressed, T4 and T3 levels are elevated
          • 123I uptake is absent
          • pts may require psychotherapy
      • Rare causes of thyrotoxicosis
        • Struma ovarii: occurs when an ovarian teratoma contains thyroid tissue and secrets thyroid hormone
          • dx confirmed by 123I uptake in pelvis on body scan
        • Hydatidiform mole: due to proliferation and swelling of trophoblasts during pregnancy w/excess production of chorionic gonatrophin which has intrinsic TSH-like activity form sharing a common TSH alpha-subunit; tx surgery
      • Hypothyroidism
        • due to deficiency of thyroid hormone
        • in infants and children hypothyroidism causes growth and development retardation; can result in mental and motor retardation
        • congenital causes include:
          • agenesis (complete absence of thyroid gland),
          • hypoplastic thyroid,
          • thyroid dyshormogenesis and
          • central hypothyroidism
      • Also known as Myxoedema results from the reduced secretion of T3 and T4 from the thyroid.
      • Hashimoto’s accounts for over 90% of the cases
      • Secondary hypothyroidism is much less common and is caused by pituitary disease [ absence of TSH leads to atrophy of thyroid gland]
      • Affects all the systems of the body, but the wide range of clinical features means that the diagnosis will be missed.
      • Dominant features in children are:
        • Reduction in growth velocity
        • Arrest of pubertal development
      • Clinical presentation in adults may vary greatly
      • Non – pitting edema [most marked on the skin of the eyelids and hands]  often associated with loss of eyebrow and scalp hair
      • Dryness of the skin
      • Reduced body hair
      • Bradycardia
      • Hypothermia
      • Pericardial and pleural effusions [ can occur and is life threatening]
      • Diagnosis is based on
        • Clinical suspicion
        • Prolonged relaxation time of peripheral reflexes
        • A low voltage EKG
        • Biochemical estimation of T4 and TSH
        • Thyroid Antibodies Assays
      • Causes of hypothyroidism
        • Autoimmune (most common Hashimotos)
        • Drugs induced (Lithium carbonate- which like iodide inhibits the release of thyroid hormones  goiter and hypothyroidism
        • Adult hypothyroidism results in slowed metabolic processes which are reversible w/tx
        • hypothyroidism is usually primary (thyroid failure), can be secondary (pituitary deficiency) or tertiary (hypothalamus deficiency), or from resistance at thyroid hormone receptor.
        • In adults, auto-immune thyroiditis (Hashimoto’s thyroiditis) is the most common cause
        • Iatrogenic causes include; 131I tx, thyroidectomy, and tx w/amiodarome or lithium, iodine excess or deficiency can cause hypothyroidism
        • clinical presentations depends on age of onset
          • infants w/congenital hypothyroidism (cretinism) may have feeding problems, open posterior fontanelle, hypotonia, and/or edematous hands and face
            • short stature, mental retardation and delayed puberty can occur if not tx’ed early
        • In adults, hypothyroidism usually develops insidiously
          • S&S: fatigue, lethargy, cold intolerance, weakness, menstrual abnormalities, cool dry skin, coarse hair or hair loss, wght gain, constipation, brittle nails, delayed tendon reflexes (severe hypothyroidism), myxedema (severe hypothyroidism), bradycardia
          • severe untreated hypothyroidism can result in myxedema coma
            • S&S: hypothermia, extreme weakness, stupor, hypoventilation, hypoglycemia and hyponatremia
            • often precipitated by by exposure, infection, psychoacitve drugs
      • Lab eval
        • serum TSH is elevated, and low free T4
        • pts w/ mild hypothyroidism; TSH is elevated w/a low to nl T4 due to pituitary sensitivity to decreased levels of circulating T3 resulting in increased TSH output
        • TSH levels >8 microU/ml should receive tx w/levothyroxine even w/ nl levels of T4
        • Secondary hypothyroidism
          • has a low or low nl morning serum TSH in the setting of hypothalamic or pituitary dysfunction
          • often serum total and free T4 are at lower limit of nl
          • secondary hypothyroidism may be due to biologically inactive, but immunulogically active TSH causing morning TSH levels to be only mildly subnormal or from nocturnal surge of TSH
        • Central (Secondary) Hypothyroidism
          • a diurnal test w/ a mid-night value of serum TSH level <1.5 times the afternoon value is indicative of central hypothyroidism
        • Hypothyroidism is associated w/ other abnormal labs
            • hypercholesterolemia,
            • elevated creatinine phosphokinase w/ and increase in MB bands (fraction characteristic of cardiac muscle),
            • anemia (normocytic, normochromic but may be macrocytic (vit B deficiency from pernicious anemia) or microcytic (nutritional deficiency or menstrual blood loss)
      • Hypothyroidism Differential Dx
        • initial S&S of hypothyroidism are subtle
        • early dx depends S&S, early symptoms often overlooked are: menorrhagia, arthralgias and myalgias
        • euthyroid sick syndrome: total and occasionally free T4 are low, TSH mildly elevated
            • must not give these pts levothyroxine
            • can be distinguished from hypothyroidism by absence of goiter, absence of antithyroid antibodies and elevated rT3 levels as well as S&S
      • Hypothyroidism tx
        • synthetic L-thyroxine
          • Tri-iodothyronine should be avoided due to rapid absorption and disappearance from stream causing uneven blood levels
        • therapeutic responses should be evaluated by S&S and TSH levels
        • pt’s w/myxedema coma: IV L-thyroxine, IV hydrocortisone, IV fluids
          • many pts recover in 2-3days w/full recovery
      • Goiter
        • enlargement of thyroid gland
          • pt’s may be euthyroid (simple goiter), hyperthyroid (toxic nodular goiter or Grave’s ds) or hypothyroid (non-toxic goiter or Hashimoto’s thyroiditis), may also be focal (adenoma or carcinoma)
          • in non-toxic goiter; inadequate thyroid hormone synthesis leads to TSH stimulation resulting in an enlarged thyroid gland -> iodine deficiency was most common cause
            • hormone replacement quickly shrinks the goiter
          • Dietary goitrogens can cause goiter
            • iodine is most common; lithium, cabbage
          • goiters may become very large causing respiratory distress, dysphagia, or hoarseness
            • surgery indicated if obstructive symptoms are present
        • Solitary Thyroid Nodules
          • thyroid nodules are common; detected in about 4% of population and about 50% at autopsy
          • Benign thyroid nodules are usually benign cyst, follicular adenomas, nodular thyroiditis, or colloid nodules
        • Although a majority are benign, some are malignant
        • major etiologic factor for thyroid cancer is childhood or adolescent exposure to head and neck radiation
          • pts w/hx of irradiation should have their thyroids palpated q 2yrs
          • “ cold “lesions require FNA because benign nodules can be “cold”
          • benign nodules should be tx’ed w/L-thyroxine w/ follow up in 6 months
      • In general, the recommended dosage is:
      • GOITER: ADULTS: 100-150 (200) mcg daily. CHILDREN UP TO AGE 14: 50-100 (150) mcg daily.
      • PREVENTIVE TREATMENT FOR RELAPSE AFTER GOITER REMOVAL: 100 mcg daily.
      • THYROID DEFICIENCY:
        • ADULTS: Initial dose of 50 mcg daily (for approximately two weeks). The daily dose may be increased by 50 mcg by intervals of approximately 14-15 days until reaching the maintenance dose of 100-200 (300) mcg daily; 2-2.5 mcg/kilo of body weight daily on the average.
        • SMALL CHILDREN: 0-6 months: 10 mcg/kilo of body weight/day; 6-12 months: 8 mcg/kg of body weight/day; 1-5 years: 6 mcg mcg/kg of body weight/day; 5-10 years: 4 mcg/kg of body weight/ day.
      • Thyroid Carcinoma
        • most common type is papillary carcinoma (60%), Follicular carcinoma (20%), anaplastic carcinoma (14%), medullary carcinoma (5%) and lymphoma (1%)
        • papillary carcinoma is associated w/ lymph node spread and local invasion
        • poor prognosis : thyroid capsule invasion, sz > 2.5 cm, age of onset >45 y/o, tall cell variant, and lymph node involvement
        • Follicular carcinoma is a bit more aggressive than papillary carcinoma
        • Anaplastic carcinoma occurs in >50 y/o, very aggressive,causes pain, dysphagia, and hoarseness; pt’s die within 1st yr
        • Medullary carcinoma is derived from calcitonin-producing follicular cells
          • may be sporadic or familial
          • measurement of serum calcitonin levels can confirm etiology
      • Thyroid Carcinoma tx
        • lobectomy for papillary or follicular carcinomas <1.5 cm in sz
          • pts require lifelong L-thyroxine tx and yearly thyroid exams
        • anaplastic carcinoma requires an isthmusectomy to confirm dx and prevent tracheal compression
      • Prognosis of well differentiated thyroid carcinoma is good
        • age of onset most important indicator
        • men >40 and women >50 y/o have higher recurrence rate of death
        • 5 yr survival rate for invasive medullary carcinoma is 50%
          • mean survival for anaplastic carcinoma is 6 months
      • The Parathyroid Glands
        • four are situated around thyroid
          • occasionally one may be in thyroid or in mediastinum
        • Parathyroid hormone (PTH)
          • secretion is controlled by serum ionized calcium primarily
            • serum level falls -> PTH secretion stimulated
            • serum level rises above nl ->secretion suppressed
            • main function -> defend against hypocalcemia
      • PTH actions
        • bone reabsorption stimulated by osteoclasts
          • causes release of phosphate and calcium into extracellular fluid (ECF)
          • stimulation of renal tubular reabsorption of calcium (and magnesium)
          • inhibition of renal tubular reabsorption of bicarbonate and phosphate
          • stimulation of synthesis of active form of vitamin D, calcitrol
            • PTH indirectly enhances intestinal absorption of calcium
      • Hypercalcemia
        • common
        • may be found in serious underlying ds or in asymptomatic patients on routine labs
        • Primary Hyperparathyroidism mcc (metastatic calcinosis cutis) in adults
          • malignancy mcc in hospitalized pt’s
        • >90% of pts w/hypercalcemia have either Primary hyperparathyroidism or a malignancy
      • Primary Hyperparathyroidism
        • S&S: CNS : lethargy progressing to coma; Neuromuscular: proximal muscle weakness, hyporeflexia GI: N/V, anorexia, constipation, peptic ulcer ds (PUD), pancreatitis Renal: polyuria, polydipsia, decreased urine concentration, impaired renal function, nephrocalcinosis, nephrolithiasis Cardiac: HTN, short QT interval, bradycardia, increased sensitivity to digitalis
        • Arthralgias, bone pain, bone cysts, gout , pseudogout
          • due to effects of PTH on bones and joints
        • Etiol: peak incidence 20-40’s
          • more common in women
          • 85% of cases present w/single parathyroid gland enlargement (Parathyroid adenoma)
          • can appear as a familial disorder or in association w/ other disorders causing hypersecretion of PTH
      • Labs:
        • serum calcium levels continuously elevated or intermittently
        • serum phosphate usually low
        • elevated urine calcium levels help distinguish pts with primary hyperparathyroidism from familial hypocalciuric hypercalcemia
        • most pts w/primary hyperparathyroidism show no radiographic evidence of bone ds
          • if found, most common finding is osteopenia
      • Primary Hyperparathyroidisn
        • DX is based on finding hypercalcemia w/ an elevate or inappropriately nl PTH lvl
          • 24hr urine should be done to R/O familial hypocalciuric hypercalcemia
          • nodule in neck more likely be a thyroid nodule than a parathyroid adenoma
        • Tx: surgical removal for symptomatic pts
        • Surgical tx for asymptomatic pts when:
          • serum calcium lvl 1.0-1.6 mg/dl above upper limit
          • hx of life threatening hypercalcemia
          • kidney stone found of abdominal x-ray
          • creatinine clearance reduced by 30%
          • reduced bone density >2 standard deviations below age and sex controls
      • Hypercalcemia of malignancy
        • occurs in 20-30% of cancer pt’s during course of their injury
      • Hypercalcemia
        • frequently seen in pts w/breast cancer, squamous carcinoma of hd, neck, lung, and kidney and hematologic malignancies , T-cell lymphomas
          • pts w/malignancies, localized bone destruction often important cause of hypercalcemia
          • hypercalcemia due to vitamin D intoxication can be due to excess ingestion of vit D or endogenous production
      • Tx of Hypercalcemia
        • aimed toward reversing underlying abnormality
        • tx indicate if symptomatic or serum calcium levels > or equal to 13mg/dl
          • hydration
          • furosemide (or etharcrynic acid) loop diuretics facilitate sodium and calcium excretion
          • glucocorticoids may lower serum lvls
          • calcitonin inhibits osteoclastic bone reabsorption
          • phosphate (caution w/severe hypercalcemia; may cause metastic calcification
          • Biophosphates inhibit osteoclast mediated bone absorption
          • gallium nitrate in selected pts w/malignancy
          • dialysis
      • Hypocalcemia
        • an abnormal reduction in serum ionized calcium concentration
          • causes: hypoparathyroidism, parathyroid hormone resistance, Vit D deficiency or resistance, chronic renal failure, hyperphosphatemia, prostate CA, acute pancreatitis, gram-neg sepsis, drugs
        • Chronic renal failure is the mcc of hypocalcemia
      • S&S: often asymptomatic
        • most frequent symptoms are: neuromuscular irritability, paresthesias (hands, ft, circumoral, muscle cramps)
        • in severe hypocalcemia
          • bronchospasm, laryngeal stridor, diplopia, blepharospasm, and seizures
          • QT prolongation, CHF, (+) chovtecks sign, (+) Troussseu sign
      • Lab findings
        • hypocalcemia due to hypoparathyroidism characterized by hyperphosphatemia
          • serum PTH is undetectable or inappropriately low for serum calcium level
        • hypocalcemia caused by malabsorption or vit D deficiency
          • serum inorganic phosphate lvs are low or nl, serum PTH increased
        • TX: calcium or vit D, thiazide diuretic in absence of PTH
      • Adrenal Gland
        • lie at superior pole of each kidney
        • composed of two distinct regions:
          • cortex
          • medulla
      • Adrenal cortex
        • three anatomical zones
          • outer: zona glumerulosa  aldosterone
          • intermediate: zona fascicualata  cortisol
          • inner: zona reticularis  adreanal androgens
      • Adrenal medulla
        • functionally related to sympathetic nervous system  catecholemines (norepinephrine and epinephrine)
      • Synthesis of all steroids  cholesterol
      • Glucocorticoids affect metabolism, CV function, behavior and inflammatory/immune response
      • Cortisol
        • natural human glucocorticoid
        • secreted by adrenal glands in response to ultradian, circadian, and stress-induced hormonal stimulation by adrenocorticotropin hormone (ACTH: corticotropin)
        • plasma levels; highest in morning
        • secretion of ACTH  pituitary; regulated by corticotropin-releasing hormone (CRH) and vasopressin
      • Glucocorticoids exert negative feedback on CRH and ACTH secretion
      • Hypothalamic-pituitary-adrenal (HPA) axis interacts w/ and influences function of reproductive, growth, and thyroid axes
      • Renin-angiotensin system  aldosterone
        • angiotensin II predominant regulator of aldosterone
      • Adrenal androgens
        • dehydroepiandosterone (DHEA)
        • dehydroepiandosterone sulfate (DHEAS)
        • androstenedione
          • all synthesized in zona reticularis under influence of ACTH
          • no intrinsic androgenic activity
            • contribute to androgenicity by peripheral conversion to testosterone and dihydrotestosterone
      • Adrenal insufficiency
        • primary: resulting from destruction or dysfunction of adrenal cortex
        • secondary: ACTH hyposecretion
      • Addison’s Disease
        • autoimmune destruction of adrenal glands
        • mcc of primary adrenal insufficiency
          • glucocorticoid and mineralcorticoids diminished
          • if untreated; fatal
          • approx 70% of pts have antiadrenal antibodies
        • Tuberculosis was formerly mcc of adrenal insufficiency; now account for <20%
          • calcified glands  50% of cases of tuberculous adrenal insufficiency
        • Congenital causes : congenital adrenal hyperplasia, adrenal unresponsiveness to ACTH, congenital adrenal hypoplasia, and two demyelinating lipid metabolism disorders
      • Adrenal insufficiency
        • commonly presents as: weight loss, increasing fatigue, vomiting, nausea, diarrhea and salt craving
        • muscle and jt pain , abdominal pain, postural dizziness
        • increased pigmentation (extensor surfaces, creases of palms, and buccal mucosa)
          • lab: hyponatremia and hyperkalemia, metabolic acidosis, azotemia, hypercalcemia, lymphocytosis, eosinophilia
        • Acute adrenal insufficiency
          • medical emergency
            • plasma cortisol level >18 micrograms/dl r/o’s dx of adrenal crisis
            • <18 micrograms/dl consistent w/ adrenal insufficiency
        • Once dx of adrenal insufficiency is made
          • need to distinguish between primary or secondary
        • Secondary adrenal insufficiency
          • results from inadequate stimulation of adrenal cortex by ACTH
            • can be from lesions anywhere in HPA axis or prolonged suppression of HPA axis by exogenous glucocorticoids
      • Secondary adrenal insufficiency
        • same manifestations as primary; except
          • no hyperpigmentation, no salt craving, no abnormalities of hyperkalemia or metabolic acidosis
          • hyponatremia often due to inapproprite ADH secretion which accompanies glucocorticoid insufficiency
            • pt’s w/ secondary adrenal insufficiency due to a pituitary lesion usually have same labs and symptoms of : hypothroidism, hypogonadism, or growth hormone deficiency
      • Labs
        • Primary adrenal insufficiency: morning plasma ACTH >50 pico-grams/dl; standing plasma renin >3 nano-grams/ml/hr
        • Secondadry adrenal insufficiency: morning plasma ACTH < 20 pico-grams/dl; standing plasma renin <3 nano-grams/ml/hr
      • Secondary adrenal insufficiency
        • occurs commonly after d/c of long term glucocorticoid therapy
      • Addisons Ds
        • requires life-long replacement of glucocorticoids and mineralocorticoids
          • initial regimen of 15-20 mg of hydrocortisone in a.m and 5 mg around 4 p.m mimics physiologic dose
          • mineralocorticoid tx varies greatly
            • synthetic mineralocorticoid fludrocortisone (florinef) 100 micrograms/dl adjusted to keep standing plasma level above 3 nano-grams/ml/hr
            • standing plasma rnin level >3 nano-grams w/ pt on correct glucocorticoid dose suggests undertreatment w/ florinef
        • Under stress of a minor illness (nausea , vomiting, or fever >100.5F) hydocortisone dose should be doubled for a short time period
        • under major stress (surgery or major trauma) 150 mg -300mg of IV hydorcortisone given in 3 divided doses; then rapidly tapering during recovery
        • pts should wear a medical alert bracelet and instructed in the use of IM hydorcortisone in emergencies
      • Hyporeninemic hypoaldosteronism
        • decreased renin secretion by kidney
          • hyperkalemia and hyperchloremic metabolic acidosis occurs
          • plasma sodium concentration usually normal
          • plasma renin and aldosterone are low and unresponsive to stimuli
        • Diabetes melitus (DM) and chronic tubulointerstitial ds of kidney are the most common underlying conditions
      • Hypersecretion of glucocorticoid hormone, cortisol, causes Cushing syndrome
      • Cushing syndrome
        • a metabolic disorder affecting carbohydrate, protein and lipid metabolism
        • increased production of cortisol seen in physiologic states: stress, last trimester of pregnancy; chronic strenuous exercise
        • Pathologic states: exogenous or endogenous Cushing syndrome, several psychiatric states (depression, alcoholism, anorexia nervosa, panic disorder, and alcohol or narcotic withdrawal)
        • Cushing syndrome may be due to exogenous ACTH or glucorticoid tx or endogenous hypersecretion
          • endogenous Cushing syndrome is either ACTH dependant or ACTH independant
        • ACTH dependant  85% of cases (pituitary causes of ACTH (Cushing Ds), ectopic sources of ACTH and ectopic sources of CRH
        • Pituitary Cushing Ds  80% of ACTH dependant Cushing syndrome
        • Ectopic ACTH  sm cell lung ca
          • remaining pts have pancreatic, adrenal, or thyroid secreting tumors of ACTH
            • ACTH independent cases  15% of Cushing syndrome ( adrenal adenomas, adrenal carcinoma, micronodular adrenal ds & autonomous macronodular adrenal ds
      • Cushing Ds
        • seen in 20-30 y/o
      • Ectopic Cushing syndrome
        • bimodal age increased incidence in children and young adults <20 y/o and in 50-60’s
        • usually insidious; mena duration for dx 3-5 yrs
          • clinical manifestations: centripetal obesity, wasting of arms and legs, rounding of face (moon facies), facial plethora, supraclavicular and temporal filling
        • Proximal muscle weakness
        • menstrual irregularities in females; decreased libido in males and impotence
        • adult onset acne or hirsutism in females
        • violacious ( purple or dark red) skin striae
        • thinning of back of hands very specific sign in young adults
        • growth arrest in pediatrics pts, pubertal arrest, virilization and menstrual irregularities frequently seen
      • Labs
        • elevated plasma alkaline phosphatase, granulocytosis, thrombocytosis, hypercholesterolemia, hypertriglyceremia and glucose intolerance/DM
          • central hypothyroidism occurs in about 70%
      • Dx approach
          • initially 90% have a urinary free cortisol (UFC) 24 hr urine collection >90 micrograms/dl
        • lvl >300 micrograms/dl very specific
        • Pseudo-Cushing states from psychiatric disorders or alcoholism frequently have levels between 90-300 micrograms/dl
        • ectopic ACTH syndrome and cortisol secreting adenomas or carcinomas frequently have UFC lvls >1000 micrograms/dl
          • cortisol normally secreted in a diurnal fashion: highest plasma concentration in a.m, lowest around midnight
          • Cushing syndrome similar to normals, afternoon and evening lvls higher, p.m lvls > 50% of a.m  Cushing syndrome
        • Imaging may be helpful in eval for etiol of hypercortisolism
          • MRI of pituitary
          • CT and MRI of adrenal gland; CT and MRI of chest and abdomen useful for ectopic ACTH secreting tumors if suspected
      • Tx
        • surgery of all Cushing syndrome tumors
          • pituitary Cushing ds tx by transphenoidal surgery (TSS)
        • pts who fail initial pituitary surgery or have recurrent Cushing ds can be tx’ed w/ pituitary radioation
          • almost all pts w/develop panhypopituitarism; so thyroid, gonadal, and even steroid tx may be needed
        • pt’s w/Cushing Ds who remain hypercortisolemic after surgery and radiation should undergo B/L adrenalectomy
      • Primary Mineralcorticoid Excess
        • manifested by salt retention, HTN, and metabolic alkalosis
        • Primary adosteronism can be due to aldosterone-producing adenoma (75%). B/L adrenal hyperplasia (22%) adrenal carcinoma (1%)
        • Secondary aldosteronism results from overactivation of the renin-angiotensin system
        • Primary aldosteronism usually recognized during eval of HTN or hypokalemia
          • curable cause of HTN
          • less than 2% of pts w/HTN have primary aldosteronism
        • Clinical manifestation
          • HTN, hypokalemia, and metabolic acidosis
            • most presenting symptoms are relate to hypokalemia
            • mild hypokalemic pts have fatigue, muscle weakness, nocturia, lassitude and HA’,
          • Severe hypokalemic pt’s have polydypsia, polyuria, paresthesias, paralysis and tetany can occur
            • positve Trousseu or Chovstek sign may occur from metabolic alkalosis
          • BP can range from borderline to severely hypertensive lvls; rarely malignant HTN
      • DX
        • hypokalemia in presence of HTN
          • elevated urinary aldosterone lvl >15 microgram/dl and a suppressed plasma renin lvl <2 nano-grams/ml/hr suggest hyperaldosteronism
        • Basal plasma aldosterone lvl <8 nano-gram/dl is found in nl individuals
        • lvls 8-20 nan-grams/dl usually found in pt’s w/ B/L adrenal hyperplasia
          • tx’ed w/spironolactone
        • lvls > 20 nano-grams/dl suggest adrenal adenoma
      • Adrenal Medulla Hyperfunction
        • adrenal medulla synthesizes the catecholamines: norepinephrine, epinephrine and dopamine from amino acid tyrosine
        • norepinephrine-the major catecholemine produce by adrenal medulla predominantly has alpha-agonist actions  vasoconstriction
        • epinephrine acts primarily on beta receptors  inotropic and chronotropic effects on ht  vasodilation,  ’s plasma glucose in response to hypoglycemia
        • Norepinephrine synthesized in CNS and in sympathetic postganglionic neurons
        • epinephrine synthesized almost entirely in adrenal medulla
      • Hypersecretion of catecholemines produces the clinical syndrome of Pheochromcytoma
        • can occur in any sympathetic ganglion
        • >90% arise in adrenal medulla
        • Pheochromocytoma occurs as part of multiple endocrine neoplasia (MEN) type 2A or 2B syndromes
          • former (Sipple’s syndrome) marked by medullary carcinoma or thyroid, hyperparathyroidism, and pheochromocytoma
          • latter characterized by medullary carcinoma of thyroid, mucosal neuromas, intestinal ganglioneuromas, marfanoid habitus and pheochromocytoma
      • Clinical manifestation
        • HTN most common finding
          • may be associated w/common triad: HA, palpitations, and sweating
          • other symptoms : flushing, anxiety, nausea, fatigue,, weight loss, abd and chest pain
            • may be precipitated by emotional stress, exercise, anesthesia, abd pressure, or intake of tyramine containin foods
          • wide fluctuations in BP may occur
          • HTN if pheochromocytoma usually does not respond to tx for HTN
      • DX
        • elevated urinary excretion of catecholamines or their metabolites
          • metenephrines, and vanillylmandelic acid (VMA)
          • lvls checked during periods of HTN
          • measurement of plasma catecholemines may also be useful
            • plasma norepinephrine lvls >1500 pico-grams/ml or an epinephrine lvl >500 pico-grams/ml
        • Tx: surgical excision

    + Miami DadeMiami Dade, 11 months ago

    custom

    1205 views, 0 favs, 0 embeds more stats

    More info about this document

    © All Rights Reserved

    Go to text version

    • Total Views 1205
      • 1205 on SlideShare
      • 0 from embeds
    • Comments 0
    • Favorites 0
    • Downloads 156
    Most viewed embeds

    more

    All embeds

    less

    Flagged as inappropriate Flag as inappropriate
    Flag as inappropriate

    Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details.

    Cancel
    File a copyright complaint
    Having problems? Go to our helpdesk?

    Categories